(Stroke. 1999;30:807-810.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (V.K., D.W.D., S.H, D.G.N., G.S.-A., E.B.R.), University of Münster; and the Department of Neurology (M.S.), Heinrich-Heine-University, Düsseldorf, Germany.
Correspondence to Vendel Kemény, MD, Department of Neurology, University of Münster, Albert-Schweitzer-Str. 33, D-48129 Münster, Germany. E-mail kemeny{at}uze.net
| Abstract |
|---|
|
|
|---|
MethodsIn 11 normal volunteers and in 11 patients with arterial or cardiac embolic sources, we performed simultaneous recordings from both middle or both posterior cerebral arteries. In the normal subjects, we produced 1342 additional artifacts to use the latter as false-positives. Detection of microembolic signals (MES) was done offline from digital audiotapes (1) by an experienced blinded investigator used as a reference and (2) by a trained 3-layerfeed-forward neural network.
ResultsFrom the 1342 provoked artifacts the neural network labeled 216 events as microemboli, yielding an artifact rejection of 85%. In microembolus-positive patients the neural network detected 282 events as emboli, among these 122 signals originating from artifacts; 58 "real" events were not detected. This result revealed a sensitivity of 73.4% and a positive predictive value of 56.7. The spectral power of the detected artifact signals was 16.5±5 dB above background signal. MES from patients with artificial heart valves had a spectral power of 6.4±2.1 dB; however, in patients with other sources of emboli, MES had an averaged energy reflection of 2.7±0.9 dB.
ConclusionsThe neural network is a promising tool for automated embolus detection, the formal algorithm for signal identification is unknown. However, extreme signal qualities, eg, strong artifacts, lead to misdiagnosis. Similar to other automated embolus detection systems, good signal quality and verification of MES by an experienced investigator is still mandatory.
Key Words: cerebral embolism image processing, computer-assisted ultrasonography, Doppler
| Introduction |
|---|
|
|
|---|
The use of a trained neural network is another attractive development for automatic embolus detection. This device uses a pattern recognition procedure to discriminate MES from the physiological/pathological blood velocity spectra and from artifacts caused by, for example, probe motion and signal overload. The neural network is trained by presenting the pattern of a lot of characteristic Doppler signals (emboli, artifacts, normal "background"). After a sufficient learning phase (more than 1 million iterations), the network could generalize its newly learned pattern recognition paradigm to similar signals during novel recordings. Unfortunately, trained networks have the disadvantages of being a "black box," of bearing the risk to be overtrained (loss of generalization), of perpetuating mistakes introduced by their "teachers" and bearing the risk of misdiagnosis of pathological signals not encountered frequently enough during the learning phase (eg, unusual velocity profiles, strong artifacts).8 12 13 14
Previous studies showed that microemboli originating from mechanical prosthetic cardiac valves are mainly gaseous.15 16 Consequently, they yield more intense signals than solid microemboli derived from thrombotic material or fatty debris.15 16 Because of their much higher relative intensity increase, echoes from gaseous microemboli are easy to identify within the normal background noise, ie, the signal of the normal flowing blood.
The purpose of this study was to assess the limits of the automatic embolus detection technique by means of a neural network. We also wanted to assess positive predictive value and sensitivity separately for gaseous and nongaseous emboli.
| Subjects and Methods |
|---|
|
|
|---|
The energy distribution of the reflected Doppler signal and
the power of the artifacts were calculated offline using the following
algorithm: e-20*log (signal of interest/background power) [dB], where
the "signal of interest" was the power averaged over 4 neighboring
FFT lines, and the background power was the average from the FFT of the
2 seconds without the signal of interest (Figure 1
).
|
Normal Subjects
Eleven young coworkers of our laboratory and medical students,
aged between 20 and 36 years, 9 men and 2 women with normal color-coded
duplex findings of their cervical and intracranial arteries and without
any cardiovascular or cerebrovascular disease in their
history participated in the study. These subjects were on no
medication. The recordings were made bilaterally from both MCAs
at a depth of 46 to 56 mm. Insonation time was 20 minutes. After
10 minutes of recording, the normal persons underwent a series
of provoked artifacts. First, the subjects opened their mouths 11
times, then, in the second minute, they coughed 10 times, in the third
minute they clicked their teeth together 10 times, in the fourth minute
they swallowed 10 times, in the fifth minute they moved their jaw 10
times horizontally, and in the sixth minute the investigator tapped 10
times against the probes. In the seventh minute the subjects read a
text aloud. That means a total of 671 artifacts were produced, ie, 1342
artifacts considering both probes of the bilateral recording
(plus a 1-minute continuous reading-period).
Patients
Subgroup I, Patients With Thromboembolic Disease
We investigated 2 women and 4 men, aged 40 to 83 years, with
potential active arterial sources of embolism. Microembolus
detection lasted 60 minutes in every patient. One patient had a
dissection of the left extracranial internal carotid artery (ICA) that
had become symptomatic with a right-sided hemiparesis 18
days before the investigation. Two patients had an ICA occlusion with
stenosis of the contralateral ICA, one of them was
asymptomatic, the other patient had had a transient
ischemic attack (TIA) 6 months before. One patient had an
asymptomatic high-grade stenosis of the right
intracranial ICA. One patient had stenoses of both ICAs with a
symptomatic infarct in the right carotid territory. One
patient had high-grade stenosis at the origin of the left
vertebral artery with a TIA in the vertebrobasilar territory. Two
patients were on intravenous heparin, 2 on ticlopidine
treatment, and 1 on aspirin. One patient was on no medication. One
53-year-old patient was investigated with an intracardiac shunt. He had
a history of TIAs in the territory of 1 ICA. He was on no antiaggregant
treatment.
Subgroup II, Patients With Mechanical Prosthetic
Cardiac Valves
Three men and 1 woman with mechanical prosthetic aortic
valves, aged 20 to 68 years, were investigated 105 to 1338 days after
cardiac surgery. One patient had an additional asymptomatic
low-grade carotid stenosis, and 3 had normal ultrasound
findings of their brain-supplying arteries. None of them had any
cerebrovascular events in the past. All patients were on oral
anticoagulation. Insonation duration was 60 minutes in this group of
patients.
Data Analysis
In the group of normal subjects the artifact rejection rate of
the network was calculated; in all the patients together and in the 2
patient subgroups considered separately, sensitivity and positive
predictive values for MES detection by the network in comparison to the
investigator's decisions were assessed.
| Results |
|---|
|
|
|---|
|
Patients
The automatic embolus detection system detected 282 events in both
groups of patients, ranging from 1 to 95 MES per individual. Among
these events, 122 signals originated from artifacts. During the offline
analysis, the blinded investigator identified a total number of
218 MES. The software did not identify 58 additional MES detected by
the investigator (cf. Table 1
).
The neural network achieved an overall sensitivity of 73.4% and a
positive predictive value of 56.7% in comparison to the experienced
human investigator.
|
In the subgroup of patients with thromboembolic sources of
emboli, the system detected a total of 174 events. Among these events,
96 signals stemmed from artifacts. Twenty-four additional MES were not
identified (cf. Table 2
). The sensitivity
for identification of true MES in this subgroup of patients was 76.5%,
and the positive predictive value was 44.8%.
|
In the subgroup of prosthetic cardiac valve patients, 108
events were recorded by the software. Among these signals, 26
events originated from artifacts. Thirty-four MES were not identified
(cf. Table 3
). The sensitivity for
identification of true MES in this subgroup of patients was 70.7%, and
the positive predictive value was 75.9%.
|
MES from patients with artificial cardiac valves had averaged energy reflections of 6.4±2.1 dB, and from patients with other sources of emboli of 2.7±0.9 dB.
| Discussion |
|---|
|
|
|---|
The present study assessed sensitivity and positive predictive
value of automated embolus detection with a trained neural network
software. In general, the neural network is capable of classifying
patterns in given categories after learning typical
examples.12 In a previous study, the neural network had
achieved a sensitivity of 93% for the detection of MES in patients
with symptomatic and asymptomatic high-grade
ICA stenoses13 ; and in patients with mechanical
prosthetic cardiac valves, Georgiadis et al had even found
identical performances of the neural network as compared with
human observers.14 The latter study, however, had the
methodological limitation that only the overall number of detected MES
had been compared and not their actual position on the tape on an
event-by-event basis. Evaluating the same software (EMBotec), Van
Zuilen et al found a network's overall sensitivity to be 62% in
patients with arterial sources of embolism as compared with
human observers.8 Again, the reason for the discrepancies
in these studies might be that the latter identified individual MES for
comparison rather than their absolute number. We also chose this
signal-by-signal approach to ensure agreement in the corresponding
identification of distinct signals. In the present study, the
neural network identified a total number of 282 events, which consisted
of 160 true MES and 122 artifacts. The true number of MES, however, was
218 according to the experienced investigator. The network's resultant
overall positive predictive value of 56.7% and overall sensitivity of
73.4% for the identification of MES are promising and are particularly
good in the group of patients with mechanical prosthetic
cardiac valves in which the positive predictive value achieved 75.9%.
However, emboli in patients with mechanical prosthetic cardiac
valves are mainly gaseous in nature and, presumably, of no harmful
clinical relevance.15 16 Their gaseous composition leads
to a stronger ultrasound scattering and an enhanced echo. Consequently,
embolic signals in the patients with prosthetic cardiac valves
are longer in duration and higher in their relative intensity increase
than solid emboli from atherosclerotic or thrombotic
sources.15 16 This is the reason why the positive
predictive value of the software used in this study is higher in
patients with prosthetic cardiac valves than in patients with
atherosclerotic or thrombotic sources of embolism. The EMBotec software
correctly rejected 85% of the provoked artifacts, although this
software version was not trained for signals with a >10 dB power (ie,
signal-to-noise ratio; Figure 2
).
The present study showed that the neural network could not reject all strong artifacts (over 10 dB). On the other hand, a variety of normal spectra in healthy subjects and patients demonstrated patterns similar to embolic signals. This is surprising, but reflects the neural network technique: all patterns for which the network has not yet been trained and those that provide extreme features, pose problems for it. Thus, the network requires a good signal-to-noise ratio and emboli signals between 1 and 10 dB. The network's decisions could be improved by a combination of a threshold algorithm and another training set of abnormal and "normal" signals.
Automated embolus detection using a neural network is a promising step forward in the routine assessment of patients at increased stroke risk. However, similar to other automated embolus detection systems, the verification of the signals by an experienced investigator is still mandatory.6 8 9
| Acknowledgments |
|---|
Received October 29, 1998; revision received December 7, 1998; accepted December 7, 1998.
| References |
|---|
|
|
|---|
2. Wolf P, Cobb JD, D'Agostino R. Epidemiology of stroke. In: Barnett H, Mohr JP, Stein B, Yatsu E, eds. Stroke: Pathophysiology, Diagnosis and Management. New York, NY: Churchill Livingstone Inc; 1992:46.
3.
Spencer MP, Thomas GI, Nicholls SC, Sauvage LR.
Detection of middle cerebral artery emboli during carotid
endarterectomy using transcranial
Doppler ultrasonography. Stroke. 1990;21:415423.
4. Padayachee TS, Parsons S, Theobold R, Linley J, Gosling RG, Deverall PB. The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial Doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg. 1987;44:298302.[Abstract]
5. Nabavi DG, Arato S, Droste DW, Schulte-Altedorneburg G, Kemény V, Reinecke H, Borggrefe M, Breithardt G, Ringelstein EB. Microembolic load in asymptomatic patients with cardiac aneurysm, severe ventricular dysfunction, and atrial fibrillation: clinical and hemorheological correlates. Cerebrovasc Dis. 1998;8:214221.[Medline] [Order article via Infotrieve]
6.
Ringelstein EB, Droste DW, Babikian VL, Evans DH,
Grosset DG, Kaps M, Markus HS, Russell D, Siebler M. Consensus on
microembolus detection by TCD. Stroke. 1998;29:725729.
7. Droste DW, Nabavi D, Hansberg T, Ritter M, Kemény V, Ringelstein EB. Detection of clinically silent circulating emboli by transcranial Doppler ultrasound: technical and clinical aspects. In: Klingelhöfer J, Bartels E, Ringelstein EB, eds. New Trends in Cerebral Hemodynamics and Neurosonology. Amsterdam, Netherlands: Elsevier Science; 1997, 393397.
8.
Van Zuilen EV, Mess WH, Jansen C, Van Der Tweel I, Van
Gijn J, Ackerstaff RGA. Automatic embolus detection compared with human
experts. A Doppler ultrasound study. Stroke. 1996;27:18401843.
9.
Droste DW, Hagedorn G, Nötzold A, Siemens H-J,
Sievers HH, Kaps M. Bigated transcranial Doppler for
the detection of clinically silent circulating emboli in normal persons
and patients with prosthetic cardiac valves. Stroke. 1997;28:588592.
10.
Georgiadis D, Goeke J, Hill M, König M, Nabavi
DG, Stögbauer F, Zunker P, Ringelstein EB. A novel technique for
identification of Doppler microembolic signals
based on the coincidence method: in vitro and in vivo evaluation.
Stroke.. 1996;27:683686.
11.
Molloy J, Markus HS. Multi-gated Doppler ultrasound
in the detection of emboli in a flow model and embolic signals in
patients. Stroke. 1996;27:15481552.
12.
Siebler M, Rose G, Sitzer M, Bender A, Steinmetz H.
Real- time identification of cerebral microemboli with US feature
detection by a neural network. Radiology. 1994;192:739742.
13.
Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H,
Freund H-J. Cerebral microembolism in symptomatic and
asymptomatic high-grade internal carotid artery
stenosis. Neurology. 1994;44:615618.
14.
Georgiadis D, Kaps M, Siebler M, Hill M, König M,
Berg J, Kahl M, Zunker P, Diehl B, Ringelstein EB. Variability of
Doppler microembolic signal counts in patients with
prosthetic cardiac valves. Stroke. 1995;26:439443.
15.
Kaps M, Hansen J, Weiher M, Tiffert K, Kayser I, Droste
DW. Clinically silent microemboli in patients with artificial
prosthetic aortic valves are predominantly gaseous and not
solid. Stroke. 1997;28:322325.
16.
Droste DW, Hansberg T, Kemény V, Hammel D,
Schulte-Altedorneburg G, Nabavi DG, Kaps M, Scheld HH, Ringelstein EB.
Oxygen inhalation can differentiate gaseous from nongaseous microemboli
detected by transcranial Doppler ultrasound.
Stroke. 1997;28:24532456.
17.
Markus HS, Bland M, Rose G, Sitzer M, Siebler M. How
good is intercenter agreement in the identification of embolic signals
in carotid artery disease? Stroke. 1996;27:12491252.
18. Ackerstaff RG, Mess WH, van Zuilen EV, van der Tweel I. Reliability in the identification of Doppler embolic transient signals: a statistical problem? Stroke. 1997;28:876. Letter.
19.
Siebler M, Sitzer M, Rose G, Bendfeldt D, Steinmetz H.
Silent cerebral embolism caused by neurologically
symptomatic high-grade carotid stenosis.
Brain. 1993;116:10051015.
20.
Markus HS, Ackerstaff R, Babikian V, Bladin C, Droste
D, Grosset D, Levi C, Russell D, Siebler M, Tegeler C. Intercenter
agreement in reading Doppler embolic signals: a multicenter
international study. Stroke. 1997;28:13071310.
This article has been cited by other articles:
![]() |
R. Dittrich, M. A. Ritter, M. Kaps, M. Siebler, K. Lees, V. Larrue, D. G. Nabavi, E. B. Ringelstein, H. S. Markus, and D. W. Droste The Use of Embolic Signal Detection in Multicenter Trials to Evaluate Antiplatelet Efficacy: Signal Analysis and Quality Control Mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) Trial Stroke, April 1, 2006; 37(4): 1065 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schoenburg, B. Kraus, A. Muehling, U. Taborski, H. Hofmann, G. Erhardt, S. Hein, M. Roth, P. R. Vogt, G. F. Karliczek, et al. The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1455 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Devuyst, G.A. Darbellay, J.-M. Vesin, V. Kemeny, M. Ritter, D.W. Droste, C. Molina, J. Serena, R. Sztajzel, P. Ruchat, et al. Automatic Classification of HITS Into Artifacts or Solid or Gaseous Emboli by a Wavelet Representation Combined With Dual-Gate TCD Stroke, December 1, 2001; 32(12): 2803 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cullinane, G. Reid, R. Dittrich, Z. Kaposzta, R. Ackerstaff, V. Babikian, D. W. Droste, D. Grossett, M. Siebler, L. Valton, et al. Evaluation of New Online Automated Embolic Signal Detection Algorithm, Including Comparison With Panel of International Experts Stroke, June 1, 2000; 31(6): 1335 - 1341. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |